Mr. Vijay Karwal
  • Independent Director
  • Member of Audit Committee
  • Chairperson of Nomination Committee
  • Chairperson of Remuneration Committee
Mr. Vijay Karwal
Age (As on 31 Dec 2023)
  • 53 Years
Education
  • Association for Investment Management & Research/CFA Institute Current holder of Chartered Financial Analyst (CFA)
  • University of Groningen, The Netherlands M.Sc. in Monetary Economics
  • University of Southampton, United Kingdom Erasmus Scholar - Department of Accounting & Management Sciences
Shared Held by Each Director (As on 30 Dec 2023)
  • None
Experiences in the past 5 Years
2021 - Present
  • Independent Director, Member of Audit Committee and Chairman of Nomination Committee and Remuneration Committee, Mega Lifesciences PCL / Manufacture and distribute nutraceutical and pharmaceutical products
2021 - Present
  • Chief Financial Officer, Executive (Non-Independent) Director, AffaMed Therapeutics, Hong Kong / developing and commercializing transformative pharmaceutical products
2021 - Present
  • Operating Partner, CBC, Group, Hong Kong (formerly C-Bridge Capital) is one of the largest and most active healthcare-dedicated investment firms in Asia
2018 - 2021
  • Managing Director, Head of Healthcare Investment Banking, Asia ex-Japan, Nomura International, Hong Kong
Back